ADILW
Adial Pharmaceuticals Inc
Halal Rating :
Last Price
$0.05
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing medications for the treatment of alcohol use disorder (AUD) and other addictive disorders. Their lead investigational product, AD04, is being developed as a treatment for individuals with AUD who have specific genetic markers.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Adial Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.